Maxim Group Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $2
HeartBeam
HeartBeam BEAT | 0.00 |
Maxim Group analyst Anthony Vendetti initiates coverage on HeartBeam (NASDAQ:
BEAT) with a Buy rating and announces Price Target of $2.
